October 2016
TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projectsAround our themes

October was scored by many events abroad, such as Japanese Mission or the US Advamed Mission... Lyonbiopole and its members took advantage of meeting potential partners and discover these specific markets.


November opens the doors of the 8th edition of Private Inv€stments Day!


On the program, roundtables and business pitches. For the first time this year, individual meetings between entrepreneurs seeking financing and investors are scheduled early in the afternoon ... Lyonbiopole goes one step further to help its members closer to their financing problematic.

Cluster's life

 Trade mission to Japan with bioXclusters PlusLyonbiopole and its partners - Biocat, BioM and BioPmed - have escorted a 26 European healthcare SMEs delegation to meet Japanese key players in health.[...]
 Scientific coordination work in the heart of the 10th Partnering DaysAround 250 professional from major groups, SMEs, and the clinical and academic worlds met and discussed their skills and expertise, worked together on technological, scientific and medical issues and also discussed health strategies and started new collaborations.
 Success for the ADVAMED 2016 trade mission !From 17 to 19 October, Lyonbiopole went to Minneapolis to attend the AdvaMed 2016 conference. This mission was supported by the Auvergne-Rhône-Alpes Region. Lyonbiopole, accompanied by Gilles Devillers, CEO of Neolys Diagnostics, participated to this unique international MedTech conference.[...]

Our member's news

 New memberCellenion offers solutions and technologies for controlled cell dispensing with applications in the fields of bioprinting and single-cell isolation. [...]
 Focus onLyonbiopole members' PX'Therapeutics, annouced strategic collaboration agreement with RELIEF THERAPEUTICS.It concerns the production of atexakin alfa, a low-dose formulation of the recombinant human protein interleukin 6. [...]
 October 4th, 2016Imaxio has entered into collaboration with Centre Léon Bérard for the preclinical development of an IMX313 based anticancer immunotherapy October 6th, 2016Theranexus has obtained an orphan drug designation from the FDA for THN102 October 14th, 2016Mathym closes its second financing round
 October 21th, 2016First Patient Randomized in Multiple Dose Cohort Of Phase 1/1b Trial with Transgene's TG1050 in Chronic Hepatitis B Patients October 25th, 2016MabDesign has created a unique nationwide directory dedicated to the French stakeholders working in the immunotherapy field October 27th, 2016Theranexus: inclusion of the first patient in its phase II clinical study
 October 27th, 2016ERYTECH Strengthens Executive Leadership Team

Save the date

 BIO-Europe Fall 2016
November 7th, 2016
8th edition of Private Investments Day
November 25th, 2016
  • Big Booster’s 2nd edition
    November 8th, 2016
  • 10th Symposium of Vaccinology
    March 20th, 2017

  • See All events

    Calls for projects

     

    EUROPE & INTERNATIONAL

  • H2020 SME instrument
    Before October 30th, 2016
  • Around our themes

     
  • Sartorius Upstream day at Accinov
    November 3th, 2016
  • LyonSysBio
    November 16th, 2016
  • Meet The Industry (MTI)
    November 17th, 2016
  • Innovation from packaging to pharmaceutical environment
    Décember 15th, 2016
  • Bâtiment Domilyon

    321, avenue Jean Jaurès

    69007 Lyon

    Tel. : +33 (0)4 72 76 53 30

    Fax : +33 (0)9 55 91 30 26

    www.lyonbiopole.com

    info@lyonbiopole.com

    TwitterLinkedInrss

     

    This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.